Company profile for SciSparc

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

SciSparc Ltd. is a specialty clinical-stage pharmaceutical company led by an experienced team of senior executives and scientists. Our focus is on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. With this focus, the Company is currently engaged in the following drug development programs based on THC and/or non-psychoactive cannabidiol (CBD): SCI-110 (formerly THX-110) for the...
SciSparc Ltd. is a specialty clinical-stage pharmaceutical company led by an experienced team of senior executives and scientists. Our focus is on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. With this focus, the Company is currently engaged in the following drug development programs based on THC and/or non-psychoactive cannabidiol (CBD): SCI-110 (formerly THX-110) for the treatment of Tourette syndrome and for the treatment of obstructive sleep apnea; SCI-160 (formerly THX-160) for the treatment of pain

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Israel
Address
Address
20 Raul Wallenberg Street, Tower A Tel Aviv
Telephone
Telephone
972-3-616-7055
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.indianpharmapost.com/news/scisparc-acquires-xylo-technologies-innovative-endoscopic-portfolio-18413

INDPHARMAPOST
01 Dec 2025

https://www.globenewswire.com/news-release/2025/11/26/3195068/0/en/SciSparc-to-Acquire-Treasury-of-Patents-for-Innovative-Medical-Endoscopy-Systems.html

GLOBENEWSWIRE
26 Nov 2025

https://www.globenewswire.com/news-release/2025/11/20/3191728/0/en/SciSparc-Neurothera-Labs-Announces-Israeli-Patent-Application-in-Collaboration-with-Clearmind-Medicine-for-Novel-Non-Hallucinogenic-Neuroplastogen-Treatment-for-Depression.html

GLOBENEWSWIRE
20 Nov 2025

https://www.globenewswire.com/news-release/2025/11/17/3189045/0/en/Clearmind-Medicine-Files-Israeli-Patent-for-Novel-Non-Hallucinogenic-Neuroplastogen-Treatment-for-Depression.html

GLOBENEWSWIRE
17 Nov 2025

https://www.globenewswire.com/news-release/2025/10/24/3172747/0/en/SciSparc-Announces-Closing-of-the-Acquisition-of-a-Publicly-Traded-Company-on-the-TSXV-to-which-it-transferred-its-Advanced-Clinical-Stage-Pharmaceutical-Portfolio.html

GLOBENEWSWIRE
24 Oct 2025

https://www.globenewswire.com/news-release/2025/10/23/3172425/0/en/SciSparc-Announces-Closing-of-the-Sale-to-N2OFF-of-Majority-Owned-Subsidiary-MitoCareX-Advancing-Drug-Discovery-for-Resistant-Cancers-Including-Pancreatic-and-Non-Small-Cell-Lung-C.html

GLOBENEWSWIRE
23 Oct 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty